Biodesix Inc (NASDAQ: BDSX) kicked off on Friday, down -14.19% from the previous trading day, before settling in for the closing price of $1.48. Over the past 52 weeks, BDSX has traded in a range of $1.11-$2.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 25.94% over the past five years. While this was happening, its average annual earnings per share was recorded 45.04%. With a float of $74.02 million, this company’s outstanding shares have now reached $145.47 million.
Let’s look at the performance matrix of the company that is accounted for 217 employees. In terms of profitability, gross margin is 77.72%, operating margin of -52.71%, and the pretax margin is -66.84%.
Biodesix Inc (BDSX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Biodesix Inc is 49.12%, while institutional ownership is 40.84%. The most recent insider transaction that took place on Nov 21 ’24, was worth 122,840. In this transaction Director of this company bought 100,000 shares at a rate of $1.23, taking the stock ownership to the 31,194,935 shares. Before that another transaction happened on Nov 21 ’24, when Company’s Director bought 35,000 for $1.16, making the entire transaction worth $40,562. This insider now owns 10,411,024 shares in total.
Biodesix Inc (BDSX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.04% per share during the next fiscal year.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Take a look at Biodesix Inc’s (BDSX) current performance indicators. Last quarter, stock had a quick ratio of 3.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
Biodesix Inc (NASDAQ: BDSX) saw its 5-day average volume 0.43 million, a positive change from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 34.24%. Additionally, its Average True Range was 0.11.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 17.20%, which indicates a significant increase from 8.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.92% in the past 14 days, which was higher than the 72.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3941, while its 200-day Moving Average is $1.5354. Nevertheless, the first resistance level for the watch stands at $1.4406 in the near term. At $1.6112, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7115. If the price goes on to break the first support level at $1.1697, it is likely to go to the next support level at $1.0694. Assuming the price breaks the second support level, the third support level stands at $0.8988.
Biodesix Inc (NASDAQ: BDSX) Key Stats
The company with the Market Capitalisation of 184.74 million has total of 145,467K Shares Outstanding. Its annual sales at the moment are 49,090 K in contrast with the sum of -52,150 K annual income. Company’s last quarter sales were recorded 18,150 K and last quarter income was -10,260 K.
